title en

Journal archive > 2013 > N 4 July-August

DEVELOPMENT AND OPTIMIZATION OF THE METHODS FOR DETERMINING ACTIVITY
OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN PLASMA

Y. M. Roka-Moya, D. D. Zhernossekov, A. S. Kondratyuk, T. V. Grinenko

Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

The activity and content of plasminogen activator inhibitor-1 (PAI-1) are important indicators of pathological processes, because its content in plasma increases at acute myocardium infarction, tumor, diabetes mellitus, etc. The present work is dedicated to the development and optimization of the methods of PAI-1 activity definition, which can be used in clinical practice. We have proposed the modification of the method COATEST PAI with the usage of chromogenic substrate S2251. According to our modification, the cyanogen bromide fragments of human fibrinogen have been changed into bovine desAB-fibrin. We have also developed the method with the usage of fibrin films. In this method fibrin is used as a stimulator of activation reaction and as a substrate at the same time. Using fibrin, the native substrate of plasmin, we provide high specificity of the reaction and exclude the cross-reaction with other plasma enzymes.

Key words: plasminogen activator inhibitor, PAI-1 activity, fibrin films, S2251 chromogenic substrate, desAB-fibrin.

The original article in Ukrainian is available for download in PDF format.

© The Ukrainian Biochemical Journal